Author:
Choi Kwang H,Higgs Brandon W,Weis Serge,Song Jonathan,Llenos Ida C,Dulay Jeannette R,Yolken Robert H,Webster Maree J
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference69 articles.
1. Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS, McEvoy JP, Perkins DO, Rothschild AJ, Sharma T, et al: Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res. 2006, 86 (1-3): 234-243. 10.1016/j.schres.2006.06.021.
2. Bender S, Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, Ruther E: Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry. 2004, 37 (Suppl 1): S46-53.
3. Ozcanli T, Erdogan A, Ozdemir S, Onen B, Ozmen M, Doksat K, Sonsuz A: Severe liver enzyme elevations after three years of olanzapine treatment: a case report and review of olanzapine associated hepatotoxicity. Prog Neuropsychopharmacol Biol Psychiatry. 2006, 30 (6): 1163-1166. 10.1016/j.pnpbp.2006.03.014.
4. Pae CU, Lim HK, Kim TS, Kim JJ, Lee CU, Lee SJ, Lee C, Paik IH: Naturalistic observation on the hepatic enzyme changes in patients treated with either risperidone or olanzapine alone. Int Clin Psychopharmacol. 2005, 20 (3): 173-176. 10.1097/00004850-200505000-00009.
5. Gaertner I, Altendorf K, Batra A, Gaertner HJ: Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses. J Clin Psychopharmacol. 2001, 21 (2): 215-222. 10.1097/00004714-200104000-00014.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献